Security key
034569103
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)
CUSIP: 034569103
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 6,741,386
- Total 13F value
- $6,808,914
- Share change
- -11,077
- SEC-reported price per share
- $1.01
- Number of holders
- 16
- Value change
- -$68,403
- Number of buys
- 6
- Number of sells
- 10
- Shares outstanding
- 41,587,315
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
16
Top holders
10
ANEB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Anebulo Pharmaceuticals, Inc. SEC filings
Anebulo Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 034569103
Recent filing periods:
Ownership snapshot
Top reported holders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Aron R. English
Disclosed value leader
22NW, LP
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
3/4/5
13F
Lead comparable stake: 51%
13D/G row: Aron R. English
Showing 1-6 of 15 holder rows.
Quick read
Aron R. English leads the comparable SEC ownership view at 51%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Aron R. English's linked filing trail.
Comparable ownership
Top 5
Aron R. English
51%
Nantahala Capital Management, LLC
8.5%
MANGROVE PARTNERS IM, LLC
6.2%
22NW, LP
37%
MORGAN STANLEY
0.96%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Aron R. English |
13D/G
3/4/5
Director, 10%+ Owner
|
51%
|
$25,877,258
21,929,880 shares
|
$0 | 24 Feb 2025 |
| Nantahala Capital Management, LLC |
13F
13D/G
Company
|
8.5%
from 13D/G
|
$7,590,812
3,036,325 shares
|
— | 30 Sep 2025 |
| MANGROVE PARTNERS IM, LLC |
13F
13D/G
Company
|
6.2%
from 13D/G
|
$6,313,130
2,525,252 shares
|
— | 30 Sep 2025 |
| 22NW, LP |
13F
Company
|
37%
|
$38,668,250
15,467,300 shares
|
— | 30 Sep 2025 |
| MORGAN STANLEY |
13F
Company
|
0.96%
|
$998,511
399,404 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.74%
|
$766,351
306,540 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
6,741,386
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
20
Q4 2025 holders
16
Holder diff
-4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend